entertainment -WSS

entertainment

author：hotspot 2025-10-01 12:11:30 - browse：59

A new lawsuit accuses the health insurer Cigna of denying claims in bulk. Julia Rendleman/Getty Images for Eventive Marketing

A new lawsuit accuses Cigna of using an algorithm to automatically deny claims in bulk instead of individually reviewing each case, putting patients on the hook for bills the health insurer otherwise would have paid.

The complaint filed Monday in the Eastern District of California says Cigna uses a system called PXDX to identify discrepancies between diagnoses and the tests and services it covers for those ailments. The company then allegedly denies claims in bulk without looking into each coverage request. California law requires insurers to give each claim a “thorough, fair, and objective investigation.”

Once the claims are denied, the company allegedly has its physician reviewers sign off on batches of denials without opening each patient’s files to conduct detailed reviews. The complaint cites a March ProPublica article, which found that over a period of two months in 2022, Cigna doctors denied over 300,000 requests for payment using PXDX, spending an average of 1.2 seconds “reviewing” each request. One doctor alone denied 121,000 claims in that time period, according to the article.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Change Healthcare cyberattack prompts Medicare loan program

WSS

Cognito secures funding to test medical device for Alzheimer's

What we need to know about Arena Bioworks

Amylyx ALS drug failure raises questions and concerns

How to bring more disabled researchers into academia

Biden administration opens offers in Medicare drug price negotiations

Even great ERs can’t make up for American health disparities

explore

entertainment

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Amylyx ALS drug failure raises questions and concerns

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

How to save PrEP access — and even expand it

Do digital therapeutics have a future in medicine?

As demand for Covid shots wanes, Moderna seeks its next success

Vertex non

United colonoscopy coverage change 'may cost lives,' doctors say

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Wikipedia

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Juul spent big to court Black leaders to promote its e

Headspace, Meta partner to launch VR meditation app for Quest

CDC marks new Covid

Vertex non

Amylyx ALS drug failure raises questions and concerns

leisure time

leisure time

knowledge

explore